UniProt ID | CCM2_HUMAN | |
---|---|---|
UniProt AC | Q9BSQ5 | |
Protein Name | Cerebral cavernous malformations 2 protein | |
Gene Name | CCM2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 444 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions (By similarity). May function as a scaffold protein for MAP2K3-MAP3K3 signaling. Seems to play a major role in the modulation of MAP3K3-dependent p38 activation induced by hyperosmotic shock (By similarity).. | |
Protein Sequence | MEEEGKKGKKPGIVSPFKRVFLKGEKSRDKKAHEKVTERRPLHTVVLSLPERVEPDRLLSDYIEKEVKYLGQLTSIPGYLNPSSRTEILHFIDNAKRAHQLPGHLTQEHDAVLSLSAYNVKLAWRDGEDIILRVPIHDIAAVSYVRDDAAHLVVLKTAQDPGISPSQSLCAESSRGLSAGSLSESAVGPVEACCLVILAAESKVAAEELCCLLGQVFQVVYTESTIDFLDRAIFDGASTPTHHLSLHSDDSSTKVDIKETYEVEASTFCFPESVDVGGASPHSKTISESELSASATELLQDYMLTLRTKLSSQEIQQFAALLHEYRNGASIHEFCINLRQLYGDSRKFLLLGLRPFIPEKDSQHFENFLETIGVKDGRGIITDSFGRHRRALSTTSSSTTNGNRATGSSDDRSAPSEGDEWDRMISDISSDIEALGCSMDQDSA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Acetylation | --MEEEGKKGKKPGI --CCCCCCCCCCCCC | 62.73 | 12436821 | |
15 | Phosphorylation | GKKPGIVSPFKRVFL CCCCCCCCCCHHHEE | 23.77 | 23401153 | |
27 (in isoform 2) | Phosphorylation | - | 41.22 | - | |
36 (in isoform 2) | Phosphorylation | - | 6.47 | 28122231 | |
65 | Ubiquitination | LLSDYIEKEVKYLGQ HHHHHHHHHHHHHHH | 59.24 | - | |
69 | Phosphorylation | YIEKEVKYLGQLTSI HHHHHHHHHHHHCCC | 22.65 | - | |
74 | Phosphorylation | VKYLGQLTSIPGYLN HHHHHHHCCCCCCCC | 19.40 | 29978859 | |
75 | Phosphorylation | KYLGQLTSIPGYLNP HHHHHHCCCCCCCCC | 35.06 | 29978859 | |
79 | Phosphorylation | QLTSIPGYLNPSSRT HHCCCCCCCCCCCCH | 9.65 | 29759185 | |
83 | Phosphorylation | IPGYLNPSSRTEILH CCCCCCCCCCHHHHH | 31.23 | 29978859 | |
84 | Phosphorylation | PGYLNPSSRTEILHF CCCCCCCCCHHHHHH | 44.47 | 29978859 | |
96 | Ubiquitination | LHFIDNAKRAHQLPG HHHHHHHHHHHCCCC | 57.27 | - | |
157 | Phosphorylation | AHLVVLKTAQDPGIS CEEEEEEECCCCCCC | 25.95 | 22199227 | |
164 | Phosphorylation | TAQDPGISPSQSLCA ECCCCCCCHHHHHHH | 25.14 | 30266825 | |
166 | Phosphorylation | QDPGISPSQSLCAES CCCCCCHHHHHHHHC | 26.13 | 30266825 | |
168 | Phosphorylation | PGISPSQSLCAESSR CCCCHHHHHHHHCCC | 29.74 | 30266825 | |
173 | Phosphorylation | SQSLCAESSRGLSAG HHHHHHHCCCCCCCC | 13.55 | 30108239 | |
174 | Phosphorylation | QSLCAESSRGLSAGS HHHHHHCCCCCCCCC | 23.13 | 30108239 | |
178 | Phosphorylation | AESSRGLSAGSLSES HHCCCCCCCCCCCCC | 33.15 | 28122231 | |
181 | Phosphorylation | SRGLSAGSLSESAVG CCCCCCCCCCCCCCC | 28.56 | 28857561 | |
183 | Phosphorylation | GLSAGSLSESAVGPV CCCCCCCCCCCCCHH | 31.07 | 28634120 | |
185 | Phosphorylation | SAGSLSESAVGPVEA CCCCCCCCCCCHHHH | 25.52 | 28348404 | |
185 (in isoform 2) | Phosphorylation | - | 25.52 | 27251275 | |
187 (in isoform 2) | Phosphorylation | - | 14.34 | 27251275 | |
206 (in isoform 2) | Phosphorylation | - | 17.49 | 27251275 | |
238 | Phosphorylation | RAIFDGASTPTHHLS HHHHCCCCCCCEECE | 40.21 | 29255136 | |
239 | Phosphorylation | AIFDGASTPTHHLSL HHHCCCCCCCEECEE | 31.50 | 23401153 | |
241 | Phosphorylation | FDGASTPTHHLSLHS HCCCCCCCEECEEEC | 23.24 | 29255136 | |
245 | Phosphorylation | STPTHHLSLHSDDSS CCCCEECEEECCCCC | 21.49 | 23927012 | |
248 | Phosphorylation | THHLSLHSDDSSTKV CEECEEECCCCCCCC | 48.70 | 23927012 | |
251 | Phosphorylation | LSLHSDDSSTKVDIK CEEECCCCCCCCEEE | 44.92 | 23403867 | |
252 | Phosphorylation | SLHSDDSSTKVDIKE EEECCCCCCCCEEEE | 38.96 | 23403867 | |
253 | Phosphorylation | LHSDDSSTKVDIKET EECCCCCCCCEEEEE | 38.75 | 23403867 | |
259 (in isoform 2) | Phosphorylation | - | 57.88 | 27251275 | |
260 (in isoform 2) | Phosphorylation | - | 21.71 | 27251275 | |
266 (in isoform 2) | Phosphorylation | - | 14.44 | 27251275 | |
273 | Phosphorylation | STFCFPESVDVGGAS EEEEEECCCCCCCCC | 24.69 | 30108239 | |
280 | Phosphorylation | SVDVGGASPHSKTIS CCCCCCCCCCCCCCC | 26.81 | 25849741 | |
283 | Phosphorylation | VGGASPHSKTISESE CCCCCCCCCCCCHHH | 34.57 | 30108239 | |
285 | Phosphorylation | GASPHSKTISESELS CCCCCCCCCCHHHHC | 32.52 | 26657352 | |
287 | Phosphorylation | SPHSKTISESELSAS CCCCCCCCHHHHCHH | 40.06 | 27732954 | |
289 | Phosphorylation | HSKTISESELSASAT CCCCCCHHHHCHHHH | 36.73 | 28387310 | |
292 | Phosphorylation | TISESELSASATELL CCCHHHHCHHHHHHH | 19.00 | 27732954 | |
294 | Phosphorylation | SESELSASATELLQD CHHHHCHHHHHHHHH | 32.14 | 27732954 | |
296 | Phosphorylation | SELSASATELLQDYM HHHCHHHHHHHHHHH | 25.35 | 27732954 | |
301 (in isoform 2) | Phosphorylation | - | 30.67 | 27251275 | |
306 (in isoform 2) | Phosphorylation | - | 6.03 | 27251275 | |
315 (in isoform 2) | Phosphorylation | - | 2.78 | 27251275 | |
382 | Phosphorylation | KDGRGIITDSFGRHR CCCCEEEECCCCCCC | 24.54 | 29255136 | |
384 | Phosphorylation | GRGIITDSFGRHRRA CCEEEECCCCCCCCE | 22.43 | 19664994 | |
393 | O-linked_Glycosylation | GRHRRALSTTSSSTT CCCCCEECCCCCCCC | 28.75 | 23301498 | |
393 | Phosphorylation | GRHRRALSTTSSSTT CCCCCEECCCCCCCC | 28.75 | 29255136 | |
394 | Phosphorylation | RHRRALSTTSSSTTN CCCCEECCCCCCCCC | 31.39 | 28450419 | |
395 | Phosphorylation | HRRALSTTSSSTTNG CCCEECCCCCCCCCC | 24.20 | 29255136 | |
396 | Phosphorylation | RRALSTTSSSTTNGN CCEECCCCCCCCCCC | 23.52 | 29255136 | |
397 | Phosphorylation | RALSTTSSSTTNGNR CEECCCCCCCCCCCC | 29.61 | 29255136 | |
398 | Phosphorylation | ALSTTSSSTTNGNRA EECCCCCCCCCCCCC | 38.73 | 29255136 | |
399 | Phosphorylation | LSTTSSSTTNGNRAT ECCCCCCCCCCCCCC | 26.65 | 29255136 | |
400 | Phosphorylation | STTSSSTTNGNRATG CCCCCCCCCCCCCCC | 42.97 | 29255136 | |
405 (in isoform 2) | Phosphorylation | - | 21.95 | 27251275 | |
406 | Phosphorylation | TTNGNRATGSSDDRS CCCCCCCCCCCCCCC | 34.07 | 25332170 | |
408 | Phosphorylation | NGNRATGSSDDRSAP CCCCCCCCCCCCCCC | 26.66 | 25332170 | |
413 | Phosphorylation | TGSSDDRSAPSEGDE CCCCCCCCCCCCCCH | 52.07 | 28985074 | |
414 (in isoform 2) | Phosphorylation | - | 16.72 | 27251275 | |
415 (in isoform 2) | Phosphorylation | - | 33.87 | 27251275 | |
416 | Phosphorylation | SDDRSAPSEGDEWDR CCCCCCCCCCCHHHH | 54.66 | 28985074 | |
416 (in isoform 2) | Phosphorylation | - | 54.66 | 27251275 | |
429 | Phosphorylation | DRMISDISSDIEALG HHHHHHHHHHHHHHC | 27.27 | 29978859 | |
430 | Phosphorylation | RMISDISSDIEALGC HHHHHHHHHHHHHCC | 42.83 | 29978859 | |
437 (in isoform 2) | Phosphorylation | - | 2.95 | 27251275 | |
438 | Phosphorylation | DIEALGCSMDQDSA- HHHHHCCCCCCCCC- | 24.48 | 27732954 | |
443 | Phosphorylation | GCSMDQDSA------ CCCCCCCCC------ | 30.19 | 30108239 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
384 | S | Phosphorylation | Kinase | STK25 | O00506 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CCM2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCM2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SMUF1_HUMAN | SMURF1 | physical | 19318350 | |
TWST2_HUMAN | TWIST2 | physical | 25814554 | |
VTM2L_HUMAN | VSTM2L | physical | 25814554 | |
KRIT1_HUMAN | KRIT1 | physical | 25814554 | |
DOK4_HUMAN | DOK4 | physical | 25814554 | |
KRIT1_HUMAN | KRIT1 | physical | 28514442 | |
ITBP1_HUMAN | ITGB1BP1 | physical | 28514442 | |
RAD21_HUMAN | RAD21 | physical | 28514442 | |
UBE3D_HUMAN | UBE3D | physical | 28514442 | |
DD19B_HUMAN | DDX19B | physical | 28514442 | |
STK26_HUMAN | STK26 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
603284 | Cerebral cavernous malformations 2 (CCM2) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384, AND MASSSPECTROMETRY. |